Grant C. Bogle

Grant C. Bogle, listed as board member, has filed trades across 2 companies (mainly through SEC (Form 4)), most often in Epizyme, Inc. and Nuvalent, Inc. Between 11 June 2021 and 15 July 2026, the trades on record add up to 10 filings.

Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.

The newest entry dates from 15 July 2026: a transaction, in Nuvalent, Inc. The median gap between a trade and its publication by SEC (Form 4) is 2 days. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.